*To the Editor:* Coronavirus disease 19 (COVID-19), a pneumonia associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2), was first identified in Wuhan, China, in December 2019, and was characterized as a pandemic by the World Health Organization on March 11, 2020. Fever, dry cough, dyspnea, fatigue, anorexia, ageusia, and anosmia are common symptoms of COVID-19. Reported skin manifestations of COVID-19 include erythematous lesions, sometimes with dengue-like petechiae,[@bib1] and urticaria and chickenpox-like vesicles.[@bib2]

We performed a retrospective observational nationwide study of skin lesions encountered during the COVID-19 pandemic in France from March 18 to April 9, 2020, in an outpatient setting of French private practices. Patients gave informed consent for the publication of their photographs. The study enrolled 277 patients, half were male, and the median age was 27 years (range, 2-98 years).

The lesions were classified into 6 categories: urticarial in 26 (9%; [Fig 1](#fig1){ref-type="fig"} , *A*), vesicular in 41 (15%; [Fig 1](#fig1){ref-type="fig"}, *B*), acral in 142 (51%; [Fig 1](#fig1){ref-type="fig"}, *C*), morbilliform in 25 (9%; [Fig 1](#fig1){ref-type="fig"}, *D* and *E*), petechial in 7 (3%), livedo reticularis in 4 (1%), and other types in 41 (15%). Some patients presented with cutaneous signs fitting in multiple categories (detailed in [Table I](#tbl1){ref-type="table"} ). Acral lesions were unexpectedly common (n = 142). Chilblain-like lesions were the most frequent of the acral lesions (106 of 142 \[75%\]; [Fig 1](#fig1){ref-type="fig"}, *C*; Supplemental Fig 1, available via Mendeley at <https://doi.org/10.17632/2f9rpvh9vd.1>). Vesicular acral (dyshidrosis-like) lesions were reported in 20 patients (14%). Acrodynia was present in 18 patients (6%), sometimes isolated.Fig 1Different types of skin rashes observed during the COVID-19 pandemic: (**A**) urticaria-like; (**B**) vesicular or chickenpox-like; (**C**) chilblains; (**D**) maculopapular; and (**E**) pityriasis rosea-like.Table ICharacteristics of the patientsCharacteristic[∗](#tbl1fnlowast){ref-type="table-fn"}No. (%) or median (range)All patients277Male sex129/259 (50)Age, y27 (2-98)SARS-Cov2 PCR test34/277 (12) Positive PCR test25/34 (74)Contact with a patient with COVID-1931/277 (11)Suggestive extracutaneous symptoms[†](#tbl1fndagger){ref-type="table-fn"}103/277 (37) Fever48/277 (17) Respiratory symptoms44/277 (16) Anosmia/ageusia18/277 (6) Digestive symptoms16/277 (6)Acrodynia18/277 (6)Morbilliform lesions25/277 (9) Male sex10/21 (48) Age, y29 (2-70) Location of lesions Trunk or limbs25/25 (100) Face2/25 (8)Acral lesions142/277 (51) Male sex67/132 (51) Age, y27 (6-73) Type of lesions Chilblains106 (75) Dyshidrosis-like lesions20 (14) Other16 (11) Location of lesions Hands23/34 (68) Feet18/34 (53)Vesicular lesion41 (15) Male sex22/38 (58) Age, y43 (8-74) Type and location of lesions Vesicles/varicella-like lesions of the trunk and limbs21 (51) Acral dyshidrosis-like lesions20 (49)Livedo reticularis4 (1) Male sex1/2 (50) Age, y15Urticarial lesions26 (9) Male sex13/23 (57) Median age (range)3 (2-23) Location of lesions Trunk and limbs24 (92) Face2 (8)Petechial lesions7 (3) Male sex5/7 (71) Age, y21 (5-70) Location of lesions Diffuse3/7 (43) Acral2/7 (29) Limbs2/7 (29)Other types of lesions[‡](#tbl1fnddagger){ref-type="table-fn"}41 (15) Male sex11/36 (31) Median age (range)40 (1-98) Location of lesions, n (%) Trunk and limbs33/41 (80) Face8/41 (20)[^1][^2][^3][^4]

Among the 277 patients, 34 had a SARS-Cov2 polymerase chain reaction (PCR) test, of which 25 (74%) were positive, and 7 of these 25 (28%) had acral lesions. Among the patients without a positive PCR test, 115 patients had suggestive extracutaneous symptoms (detailed in [Table I](#tbl1){ref-type="table"}) or reported a close contact with a patient with COVID-19, or both. In addition, 59 patients had isolated chilblains (without any past history of chilblains and in the absence of cold exposure), without associated extracutaneous symptoms; this may suggest cutaneous symptoms of COVID-19, because this finding has been documented in some patients with a positive SARS-Cov2 PCR test in our case series and in 2 recently published case reports.[@bib3] ^,^ [@bib4] Histologic examination of 3 chilblain-like lesions showed a lichenoid dermatitis with a perivascular and eccrine mononuclear infiltrate and vascular microthrombi in 2 cases.

Owing to the retrospective, outpatient setting and the limited number of available SARS-Cov2 PCR tests in France to date, most patients were not tested. However, the number of observed chilblain-like lesions in patients without significant past medical history is extremely unusual during the spring season in France, especially because people are staying inside, and may suggest a link with COVID-19.

Finally, the presence of microthrombi in patients with chilblains is consistent with the altered coagulation status observed in patients with severe COVID-19.[@bib5] Although the number of tested patients does not allow us to draw firm conclusions regarding a direct link between SARS-Cov2 and these skin lesions, the unexpected outbreak of acral skin lesions in this epidemic context requires further investigation.
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[^1]: *PCR*, Polymerase chain reaction; *SARS-Cov2*, severe acute respiratory syndrome coronavirus 2.

[^2]: Some patients presented with cutaneous signs fitting in multiple categories.

[^3]: There were 19 patients who reported suggestive extracutaneous symptoms and contact with a patient with COVID-19.

[^4]: Including eczema-like, angiomatous, and annular lesions.
